Table 1.
Baseline demographic characteristics of N = 15 subjects
| Age (years) | 52 (38–61) | |
| BMI | < 30 | 6 (40%) |
| > 30 | 9 (60%) | |
| Sex | Female | 14 (93.3%) |
| Male | 1 (6.7%) | |
| Ethnicity | Hispanic or Latino | 4 (26.6%) |
| Not Hispanic or Latino | 11 (73.3%) | |
| Race | Black or African American | 1 (6.7%) |
| White | 14 (93.3%) | |
| Concomitant medications | DMARDs or Glucocorticoids | 13 (86.7%) |
| Biologic DMARDs | 12 (80%) | |
| Synthetic DMARDs | 10 (66.7%) | |
| Glucocorticoids | 6 (40%) | |
| Disease duration (years) | 11.4 (6.20–26.4) | |
BMI, body mass index; DMARDs, disease modifying anti-rheumatic drugs statistics represented: median (IQR); n (%)